News - Page 36 - Psychedelic Alpha

Read more about the article Natural Medicine Advisory Bulletin #1: Background

Natural Medicine Advisory Bulletin #1: Background

Post published:July 5, 2023
Post category:Colorado Natural Medicine Advisory Bulletin

Read more about the article FILAMENT HEALTH ENTERS EXCLUSIVE LICENSING AGREEMENT WITH NEOLUMINA BIOSCIENCE INC.

FILAMENT HEALTH ENTERS EXCLUSIVE LICENSING AGREEMENT WITH NEOLUMINA BIOSCIENCE INC.

Post published:June 30, 2023
Post category:Press Release

Read more about the article Psychedelic Bulletin #140: Regulators Weigh in on Psychedelics; Psychedelic Biotech Strikes Big Pharma Agreement; GH Publishes 5-MeO-DMT Trial

Psychedelic Bulletin #140: Regulators Weigh in on Psychedelics; Psychedelic Biotech Strikes Big Pharma Agreement; GH Publishes 5-MeO-DMT Trial

Post published:June 29, 2023
Post category:Psychedelic Bulletin

Read more about the article Reunion Neuroscience Reports Fiscal Fourth Quarter and Full Year 2023 Financial Results and Provides a Corporate Update

Reunion Neuroscience Reports Fiscal Fourth Quarter and Full Year 2023 Financial Results and Provides a Corporate Update

Post published:June 29, 2023
Post category:Press Release

Read more about the article Numinus to Host Q3 2023 Results Conference Call on July 17, 2023

Numinus to Host Q3 2023 Results Conference Call on July 17, 2023

Post published:June 29, 2023
Post category:Press Release

Read more about the article Psychedelic Research Bulletin: May 2023

Psychedelic Research Bulletin: May 2023

Post published:June 29, 2023
Post category:News Psychedelics Research Review

Read more about the article Small Pharma Reports Financial Results for the Fiscal Year Ended February 28, 2023 and Recent Business Highlights

Small Pharma Reports Financial Results for the Fiscal Year Ended February 28, 2023 and Recent Business Highlights

Post published:June 28, 2023
Post category:Press Release

Read more about the article An Abridged History of Psychedelic Use and Criminalisation

An Abridged History of Psychedelic Use and Criminalisation

Post published:June 27, 2023
Post category:Analysis

Read more about the article PharmaTher Initiates Filing of Abbreviated New Drug Application for KETARX™ (racemic ketamine) to the FDA

PharmaTher Initiates Filing of Abbreviated New Drug Application for KETARX™ (racemic ketamine) to the FDA

Post published:June 27, 2023
Post category:Press Release

Read more about the article BetterLife Fast Tracks Its US Patent for BETR-001 and Other LSD Derivatives

BetterLife Fast Tracks Its US Patent for BETR-001 and Other LSD Derivatives

Post published:June 27, 2023
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.